127 related articles for article (PubMed ID: 29334836)
41. Tissue-specific nuclear architecture and gene expression regulated by SATB1.
Cai S; Han HJ; Kohwi-Shigematsu T
Nat Genet; 2003 May; 34(1):42-51. PubMed ID: 12692553
[TBL] [Abstract][Full Text] [Related]
42. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
43. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
Darr J; Klochendler A; Isaac S; Eden A
Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
[TBL] [Abstract][Full Text] [Related]
44. Expression and biological roles of SATB1 in human bladder cancer.
Han B; Luan L; Xu Z; Wu B
Tumour Biol; 2013 Oct; 34(5):2943-9. PubMed ID: 23696028
[TBL] [Abstract][Full Text] [Related]
45. [Effect of PIH1D1 on the degradation of its binding protein SNF5].
Zhai N; Zhang Y; Shen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Dec; 31(6):756-9. PubMed ID: 20078948
[TBL] [Abstract][Full Text] [Related]
46. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
[TBL] [Abstract][Full Text] [Related]
47. Chromatin organizer SATB1 as a novel molecular target for cancer therapy.
Mir R; Pradhan SJ; Galande S
Curr Drug Targets; 2012 Dec; 13(13):1603-15. PubMed ID: 22998183
[TBL] [Abstract][Full Text] [Related]
48. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis.
Fessing MY; Mardaryev AN; Gdula MR; Sharov AA; Sharova TY; Rapisarda V; Gordon KB; Smorodchenko AD; Poterlowicz K; Ferone G; Kohwi Y; Missero C; Kohwi-Shigematsu T; Botchkarev VA
J Cell Biol; 2011 Sep; 194(6):825-39. PubMed ID: 21930775
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
50. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D
Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549
[TBL] [Abstract][Full Text] [Related]
52. Sézary syndrome: old enigmas, new targets.
Nicolay JP; Felcht M; Schledzewski K; Goerdt S; Géraud C
J Dtsch Dermatol Ges; 2016 Mar; 14(3):256-64. PubMed ID: 26972187
[TBL] [Abstract][Full Text] [Related]
53. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
[TBL] [Abstract][Full Text] [Related]
54. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.
Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A
EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077
[TBL] [Abstract][Full Text] [Related]
55. The alterations in SATB1 and nuclear F-actin expression affect apoptotic response of the MCF-7 cells to geldanamycin.
Grzanka D; Izdebska M; Klimaszewska-Wisniewska A; Gagat M
Folia Histochem Cytobiol; 2015; 53(1):79-87. PubMed ID: 25809470
[TBL] [Abstract][Full Text] [Related]
56. The Role of SATB1 in Tumour Progression and Metastasis.
Glatzel-Plucińska N; Piotrowska A; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450715
[TBL] [Abstract][Full Text] [Related]
57. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
[TBL] [Abstract][Full Text] [Related]
58. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo.
Pavan Kumar P; Purbey PK; Sinha CK; Notani D; Limaye A; Jayani RS; Galande S
Mol Cell; 2006 Apr; 22(2):231-43. PubMed ID: 16630892
[TBL] [Abstract][Full Text] [Related]
60. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
